Compass Pathways stock reaches 52-week high at 12.48 USD
Corroborated by 2 sources from 2 publishers
globalbusiness5d ago
TL;DR
Reports differ across sources; according to seekingalpha.com, aDSs of psilocybin therapy concern COMPASS Pathways plc (CMPS) have rallied roughly 70% since President Trump signed an executive order accelerating the development of and access to psychedelic drugs.